Identifying a clinically applicable mutational burden threshold as a potential biomarker of response to immune checkpoint therapy in solid tumors

Anshuman Panda, Anil Betigeri, Kalyanasundaram Subramanian, Jeffrey S. Ross, Dean C. Pavlick, Siraj Ali, Paul Markowski, Ann Silk, Howard L. Kaufman, Edmund Lattime, Janice M. Mehnert, Ryan Sullivan, Christine M. Lovly, Jeffrey Sosman, Douglas B. Johnson, Gyan Bhanot, Shridar Ganesan*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Fingerprint

Dive into the research topics of 'Identifying a clinically applicable mutational burden threshold as a potential biomarker of response to immune checkpoint therapy in solid tumors'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS

Immunology and Microbiology